Comment from Evan Couture

Summary: Evan H. Couture argues that the FDA should allow the sale of pasteurized equine urine as a low-potency fluid supplement, citing a regulatory contradiction where the agency permits concentrated equine urine in pill form (Premarin) but prohibits it in liquid form. The commenter contends that if pasteurization is sufficient for dairy milk, it should be sufficient for equine urine, and argues that the current ban constitutes viewpoint discrimination to protect corporate monopolies.